Terms: = Sarcomas AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Clinical Outcome
116 results:
1. Multimodal profiling of chordoma immunity reveals distinct immune contextures.
van Oost S; Meijer DM; Ijsselsteijn ME; Roelands JP; van den Akker BEMW; van der Breggen R; Briaire-de Bruijn IH; van der Ploeg M; Wijers-Koster PM; Polak SB; Peul WC; van der Wal RJP; de Miranda NFCC; Bovee JVMG
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38272563
[TBL] [Abstract] [Full Text] [Related]
2. Discovery of pathway-independent protein signatures associated with clinical outcome in human cancer cohorts.
Konaté MM; Li MC; McShane LM; Zhao Y
Sci Rep; 2022 Nov; 12(1):19283. PubMed ID: 36369472
[TBL] [Abstract] [Full Text] [Related]
3. Enhancing an Oxidative "Trojan Horse" Action of Vitamin C with Arsenic Trioxide for Effective Suppression of KRAS-Mutant Cancers: A Promising Path at the Bedside.
Burska AN; Ilyassova B; Dildabek A; Khamijan M; Begimbetova D; Molnár F; Sarbassov DD
Cells; 2022 Nov; 11(21):. PubMed ID: 36359850
[TBL] [Abstract] [Full Text] [Related]
4. Blocking FSTL1 boosts NK immunity in treatment of osteosarcoma.
Ogiwara Y; Nakagawa M; Nakatani F; Uemura Y; Zhang R; Kudo-Saito C
Cancer Lett; 2022 Jul; 537():215690. PubMed ID: 35439537
[TBL] [Abstract] [Full Text] [Related]
5. Pan‑cancer analyses reveal the regulation and clinical outcome association of PCLAF in human tumors.
Liu X; Cheng C; Cai Y; Gu Y; Wu Y; Chen K; Wu Z
Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35425993
[TBL] [Abstract] [Full Text] [Related]
6. Tetrandrine suppresses the growth of human osteosarcoma cells by regulating multiple signaling pathways.
Wang N; Yang S; Tan T; Huang Y; Chen Y; Dong C; Chen J; Luo X
Bioengineered; 2021 Dec; 12(1):5870-5882. PubMed ID: 34477474
[TBL] [Abstract] [Full Text] [Related]
7. Oncolytic virotherapy promotes radiosensitivity in soft tissue sarcoma by suppressing anti-apoptotic MCL1 expression.
Omori T; Tazawa H; Yamakawa Y; Osaki S; Hasei J; Sugiu K; Komatsubara T; Fujiwara T; Yoshida A; Kunisada T; Urata Y; Kagawa S; Ozaki T; Fujiwara T
PLoS One; 2021; 16(4):e0250643. PubMed ID: 33886686
[TBL] [Abstract] [Full Text] [Related]
8. ELK1-induced upregulation lncRNA LINC02381 accelerates the osteosarcoma tumorigenesis through targeting CDCA4 via sponging miR-503-5p.
Bian X; Sun YM; Wang LM; Shang YL
Biochem Biophys Res Commun; 2021 Apr; 548():112-119. PubMed ID: 33640603
[TBL] [Abstract] [Full Text] [Related]
9. High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies.
Toulmonde M; Lucchesi C; Verbeke S; Crombe A; Adam J; Geneste D; Chaire V; Laroche-Clary A; Perret R; Bertucci F; Bertolo F; Bianchini L; Dadone-Montaudie B; Hembrough T; Sweet S; Kim YJ; Cecchi F; Le Loarer F; Italiano A
EBioMedicine; 2020 Dec; 62():103131. PubMed ID: 33254023
[TBL] [Abstract] [Full Text] [Related]
10. Prevalence and potentially prognostic value of C-circles associated with alternative lengthening of telomeres in canine appendicular osteosarcoma.
Bicanova L; Kreilmeier-Berger T; Reifinger M; Holzmann K; Kleiter M
Vet Comp Oncol; 2021 Jun; 19(2):222-231. PubMed ID: 33211388
[TBL] [Abstract] [Full Text] [Related]
11. CXCL13/CXCR5 Interaction Facilitates VCAM-1-Dependent Migration in Human Osteosarcoma.
Liu JF; Lee CW; Lin CY; Chao CC; Chang TM; Han CK; Huang YL; Fong YC; Tang CH
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847038
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological and prognostic value of NADPH oxidase 2 (NOX2) in primary osteosarcoma.
Lin RJ; Huang Z; Wang SL; Chen H; Wei HX; Shen RK; Yang LY; Lin JH
J Orthop Sci; 2021 May; 26(3):466-472. PubMed ID: 32402505
[TBL] [Abstract] [Full Text] [Related]
13. Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine sarcomas and Selected Human Tumors.
Ponzetta A; Carriero R; Carnevale S; Barbagallo M; Molgora M; Perucchini C; Magrini E; Gianni F; Kunderfranco P; Polentarutti N; Pasqualini F; Di Marco S; Supino D; Peano C; Cananzi F; Colombo P; Pilotti S; Alomar SY; Bonavita E; Galdiero MR; Garlanda C; Mantovani A; Jaillon S
Cell; 2019 Jul; 178(2):346-360.e24. PubMed ID: 31257026
[TBL] [Abstract] [Full Text] [Related]
14. LSINCT5 predicts unfavorable prognosis and exerts oncogenic function in osteosarcoma.
He W; Lu M; Xiao D
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30967495
[TBL] [Abstract] [Full Text] [Related]
15. Fascin-1 enhances experimental osteosarcoma tumor formation and metastasis and is related to poor patient outcome.
Arlt MJ; Kuzmanov A; Snedeker JG; Fuchs B; Silvan U; Sabile AA
BMC Cancer; 2019 Jan; 19(1):83. PubMed ID: 30654764
[TBL] [Abstract] [Full Text] [Related]
16. Long noncoding RNA Breast cancer antiestrogen resistance 4 is associated with cancer progression and its significant prognostic value.
Zhao W; Wang Z; Fang X; Li N; Fang J
J Cell Physiol; 2019 Aug; 234(8):12956-12963. PubMed ID: 30537165
[TBL] [Abstract] [Full Text] [Related]
17. MicroRNA-1270 is associated with poor prognosis and its inhibition yielded anticancer mechanisms in human osteosarcoma.
Zhong L; Zheng C; Fang H; Xu M; Chen B; Li C
IUBMB Life; 2018 Jul; 70(7):625-632. PubMed ID: 29774985
[TBL] [Abstract] [Full Text] [Related]
18. CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma Cells.
Liu T; Yan Z; Liu Y; Choy E; Hornicek FJ; Mankin H; Duan Z
Cell Physiol Biochem; 2018; 46(3):1218-1230. PubMed ID: 29672299
[TBL] [Abstract] [Full Text] [Related]
19. Recurrent Kaposi sarcoma associated with Koebner phenomenon in two HIV-seronegative patients: Two case reports and a review of the literature.
Marino D; Calabrese F; Ottaviano G; La Torre FB; Vicario M; Alaibac M; Calabrò ML
Medicine (Baltimore); 2017 Dec; 96(52):e9467. PubMed ID: 29384936
[TBL] [Abstract] [Full Text] [Related]
20. Effect and Mechanism of
Li X; Liu LF; Liu YZ; Pan YT; Li G; Lu QY; Li ZC
Balkan Med J; 2018 Mar; 35(2):155-162. PubMed ID: 29363485
[TBL] [Abstract] [Full Text] [Related]
[Next]
